OSI-7904
OSI-7904 is a liposomal tetrahydrouridine (THU) prodrug of the antineoplastic fluoropyrimidine 5-fluorouracil (5-FU). It is developed by OSI Pharmaceuticals and is currently in clinical trials for the treatment of various types of cancer.
Mechanism of Action[edit]
OSI-7904 is a prodrug that is converted into 5-FU in the body. 5-FU is a fluoropyrimidine drug that inhibits thymidylate synthase, an enzyme necessary for DNA synthesis. By inhibiting this enzyme, 5-FU disrupts DNA synthesis and prevents the growth and proliferation of cancer cells.
The liposomal formulation of OSI-7904 allows for targeted delivery of the drug to cancer cells, reducing the systemic toxicity associated with 5-FU. The liposomes are designed to accumulate in the tumor tissue, where they release the drug directly into the cancer cells.
Clinical Trials[edit]
OSI-7904 has been tested in several clinical trials for the treatment of various types of cancer, including colorectal cancer, pancreatic cancer, and non-small cell lung cancer. The results of these trials have shown that OSI-7904 has a favorable safety profile and shows promise as a potential treatment for these types of cancer.
Future Directions[edit]
Further clinical trials are needed to determine the optimal dosing and administration schedule for OSI-7904, as well as to evaluate its efficacy in combination with other anticancer drugs. OSI Pharmaceuticals is currently conducting these trials.
See Also[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
